Approval · Notice of Compliance 8430 · 2006
MAVIK: Notice of Compliance 8430
Issued November 28, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8430
- Date
- November 28, 2006
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the product monograph
- Therapeutic class
- Angiotensin-converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MAVIK | Not yet assigned | — |
Medicinal ingredients
- TRANDOLAPRIL 0.5 MG per CAP
- TRANDOLAPRIL 1 MG per CAP
- TRANDOLAPRIL 2 MG per CAP
- TRANDOLAPRIL 4 MG per CAP